Drug industry and bribes
Annertz, Mårten.
Lakartidningen 101(15-16): 1436
2004
ISSN/ISBN: 0023-7205 PMID: 15146680 Document Number: 583142
Document emailed within 1 workday
Related Documents
Robinson, D.S. 1994: Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. a pharmaceutical industry perspective on drug labeling Psychopharmacology Bulletin 30(1): 23-25Lerch, C. 1994: Responsibility for patient education in drug therapy from the viewpoint of the drug industry Zeitschrift für Arztliche Fortbildung 88(12): 1055-1060
Armetti, L. 1999: Round table: The Italian Pharmacology Society and the drug industry: new processes in drug discovery and the contribution of universities Bollettino chimico farmaceutico 138(11): 596-598
Olofsson, C. 1978: Bollnäs 1978: threat and bribes to solve summer crisis Vardfacket 2(10): 21
Hallager, K. 2004: Physicians and drug industry Ugeskrift for Laeger 166(21): 2069
Pendleton, C. 2016: Transparency in drug industry relationships Nursing Times 112(21-23): 16
Habel, L. 1989: A first in the drug industry--the underpinnings of a pill Nursing Quebec 9(2): 11
Schwartz, H. 1981: Medical costs and the drug industry Medical Times 109(3): 21s-24s; 28s
Amédée-Manesme, O. 2000: Strategic analysis and the drug industry Therapie 55(2): 313-317
Schacter, L.P.; Anderson, C.; Canetta, R.M.; Kelley, S.; Nicaise, C.; Onetto, N.; Rozencweig, M.; Smaldone, L.; Winograd, B. 1992: Drug discovery and development in the pharmaceutical industry Seminars in Oncology 19(6): 613-621
Ziegler, R. 2006: Benefits and risks of drug industry "sponsorship" Medizinische Monatsschrift für Pharmazeuten 29(5): 193-194
Modestin, J. 1970: Psychotropic drug therapy and pharmaceutical industry Arzneimittel-Forschung 20(7): 877-879
Geursen, R. 1996: The drug industry and research: status in Germany Zentralblatt für Chirurgie 121(7): 603-605
Personeus, G.R.; Ascione, P. 1981: Preparation and use of drug master files in the pharmaceutical industry Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 35(2): 63-69
Håkansson, J. 2003: "Others are influenced, not me!" Physicians are often not aware how manipulated they are by drug industry Lakartidningen 100(50): 4158-4159
Wolfe, S.M. 2014: Does $760 m a year of industry funding affect the FDA's drug approval process? Bmj 349: G5012
Kopf, R. 1980: Drug legislation 1976: cost analysis for the pharmaceutical industry Der Internist 21(6): 333-338
Zajaczkowska-Białowas, L.; Nowicka, J.; Kuc, B.; Sibora, P. 1989: Studies of lysozyme activity in the saliva of workers in the drug industry Medycyna Pracy 40(5): 321-327
Wagler, M. 1970: Standardization as a basis planning and administration in drug industry and pharmacy (II) Pharmazeutische Praxis 7: 151-153
2016: Drug packaging in 2015: risky industry choices and lax regulation Prescrire International 25(172): 159-163